Detalhe da pesquisa
1.
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
J Infect Dis
; 215(11): 1711-1719, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591778